7G BioVentures I, L.P. — Form D/A
7G BioVentures I, L.P. of Belmont, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2023-11-01. The offering totals $100.0M, of which $32.7M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-11-01
- Form: D/A
- Accession: 0001889714-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $100.0M
- Amount sold: $32.7M
- Remaining: $67.3M
- Minimum investment: $100K
- Investors: 24
- Date of first sale: 2021-11-30
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-422776
Issuer
- Name: 7G BioVentures I, L.P.
- CIK: 0001889714
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1730 Belburn Drive, Belmont, CA, 94002
- Phone: 805-405-8658
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Wenkai Xiang | Executive Officer | Walpole, MA |
Other filings by this issuer (1)
More